Dan Roden
Faculty Member
Last active: 2/8/2016

  1. Striking In vivo phenotype of a disease-associated human SCN5A mutation producing minimal changes in vitro. Watanabe H, Yang T, Stroud DM, Lowe JS, Harris L, Atack TC, Wang DW, Hipkens SB, Leake B, Hall L, Kupershmidt S, Chopra N, Magnuson MA, Tanabe N, Knollmann BC, George AL, Roden DM (2011) Circulation 124(9): 1001-11
    › Primary publication · 21824921 (PubMed) · PMC3297976 (PubMed Central)
  2. SCN5A variation is associated with electrocardiographic traits in the Jackson Heart Study. Jeff JM, Brown-Gentry K, Buxbaum SG, Sarpong DF, Taylor HA, George AL, Roden DM, Crawford DC (2011) Circ Cardiovasc Genet 4(2): 139-44
    › Primary publication · 21325150 (PubMed) · PMC3080430 (PubMed Central)
  3. Refining repolarization reserve. Roden DM, Abraham RL (2011) Heart Rhythm 8(11): 1756-7
    › Primary publication · 21708111 (PubMed) · PMC3923504 (PubMed Central)
  4. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Skinner JR, Crawford J, Smith W, Aitken A, Heaven D, Evans CA, Hayes I, Neas KR, Stables S, Koelmeyer T, Denmark L, Vuletic J, Maxwell F, White K, Yang T, Roden DM, Leren TP, Shelling A, Love DR, Cardiac Inherited Disease Group New Zealand (2011) Heart Rhythm 8(3): 412-9
    › Primary publication · 21070882 (PubMed)
  5. Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Gong IY, Tirona RG, Schwarz UI, Crown N, Dresser GK, Larue S, Langlois N, Lazo-Langner A, Zou G, Roden DM, Stein CM, Rodger M, Carrier M, Forgie M, Wells PS, Kim RB (2011) Blood 118(11): 3163-71
    › Primary publication · 21725053 (PubMed)
  6. Pharmacogenomics: will the promise be fulfilled? Altman RB, Kroemer HK, McCarty CA, Ratain MJ, Roden D (2011) Nat Rev Genet 12(1): 69-73
    › Primary publication · 21116304 (PubMed) · PMC3098748 (PubMed Central)
  7. Pharmacogenomics: the genetics of variable drug responses. Roden DM, Wilke RA, Kroemer HK, Stein CM (2011) Circulation 123(15): 1661-70
    › Primary publication · 21502584 (PubMed) · PMC3093198 (PubMed Central)
  8. Pharmacogenomics at the tipping point: challenges and opportunities. Roden DM, Tyndale RF (2011) Clin Pharmacol Ther 89(3): 323-7
    › Primary publication · 21326256 (PubMed)
  9. Pharmacogenomics: application to the management of cardiovascular disease. Johnson JA, Cavallari LH, Beitelshees AL, Lewis JP, Shuldiner AR, Roden DM (2011) Clin Pharmacol Ther 90(4): 519-31
    › Primary publication · 21918509 (PubMed) · PMC3190669 (PubMed Central)
  10. Pharmacogenetics: call to action. Relling MV, Guchelaar HJ, Roden DM, Klein TE (2011) Clin Pharmacol Ther 90(4): 507; author reply 507-8
    › Primary publication · 21881564 (PubMed)